Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSCommunicate SAEs, SUSARs, and other significant events to sites around the world with the Safety Notifications module of the IQVIA Investigator Site Portal
If keeping up with the volume of safety letters you need to distribute to investigators during clinical trials is becoming more of a struggle, then you’re not alone. That’s because global safety regulations have grown exponentially over the past two decades. At the same time, trials have grown more complex by every measure.
With no sign of these trends reversing, your current use of manual trackers along with email or even various postal and parcel carrier systems to distribute safety notifications is unsustainable and may lead to compliance risks. You need a solution that can scale with the growing matrix of trials, investigators, countries, molecules, safety report types, and distribution rules.
You may have tried other electronic safety notifications solutions and are disappointed that they didn’t meet the demands of your investigators and site staff. What if you could have an enterprise-level solution for safety letter distribution that’s proven to provide fast performance, secure communication, and high-efficiency features that make sites happy?
I like the new dashboard, and we feel it is very easy to use. It is very fast compared to systems I have used from other Sponsors.
The Safety Notifications module of the IQVIA Investigator Site Portal gives you a simple, centralized solution for creating and distributing alerts about SUSARs, SAEs, events of interest, and aggregate safety reports to investigators that are studying your compounds around the world.
Powerful workflow ensures that notifications arrive within regulated timeframes according to reporting rules, while advanced logic ensures duplicate safety letters across studies and molecules are eliminated.
Pull in recipients, countries, studies and sites from your CTMS, saving time and eliminating human error.
Easily edit and adapt specific report types that can be used for future Safety Notifications, indicating timelines to be followed, roles to included or excluded, and country-specific behavior.
Use our system’s standard templates to create Safety Notifications and easily update or further configure specific Safety Notifications prior to distribution or throughout.
Easily download and acknowledge Safety Notifications in bulk, using robust searching and filtering to identify targeted Safety Notifications in seconds.
Use our broad suite of reports to track and monitor Safety Notification distribution, acknowledgement email notifications and more
| 1000s | Active studies | |
| 100,000s | Active users | |
| 1,000,000s | Safety notifications distributed | |
| Nearly 90% | Site acknowledgement compliance rate | |
Increase transparency, improve communications and reduce administrative burden for all clinical trial stakeholders.
Communication, collaboration and transparency between sites and sponsors mean trials start up and close out faster.
Give your sites the courses and credits they need to succeed with the Learning Management module of the Investigator Site Portal.
